Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Paul Ausick | Jul 20, 2015 at 9:35 AM EDT

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been…

Jon C. Ogg | Jul 15, 2015 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone, Wells Fargo and More

Wednesday's top analyst upgrades, downgrades and initiations include Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone and Wells Fargo.

Lee Jackson | Jul 14, 2015 at 10:20 AM EDT

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…

Chris Lange | Jul 7, 2015 at 7:35 AM EDT

5 Big Upcoming FDA Decisions Expected in July

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and…

Lee Jackson | Jul 2, 2015 at 9:05 AM EDT

4 Merrill Lynch Catalyst-Driven Stock Ideas to Buy Now

A new research report from Merrill Lynch features the catalyst-driven stocks ideas for the third quarter. These four had the…

Chris Lange | Jun 26, 2015 at 11:35 AM EDT

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?

Paul Ausick | Jun 26, 2015 at 11:10 AM EDT

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must…

Jon C. Ogg | Jun 25, 2015 at 9:25 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix, AT&T and More

Thursday's top analyst upgrades, downgrades and initiations include Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix and AT&T.

Lee Jackson | Jun 22, 2015 at 8:36 AM EDT

4 Top New Growth Stock Picks From Jefferies

ThinkstockAs we get closer to second quarter earnings, many investors on Wall Street and Main Street are starting to concentrate…

Chris Lange | Jun 18, 2015 at 11:45 AM EDT

Key Analyst Sees Solid Upside in Eli Lilly

Eli Lilly has made a big splash in the market over the past year. A key analyst sees this trend…

Jon C. Ogg | Jun 18, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Bankrate, Eli Lilly, Embraer, Oracle, Southwest Air and More

Thursday's top analyst upgrades, downgrades and initiations include Bankrate, Eli Lilly, Embraer, Oracle and Southwest Airlines.

Jon C. Ogg | Jun 17, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Arista, Baidu, Chevron, Lexmark, Occidental, Salesforce and More

Wednesday's top analyst upgrades, downgrades and initiations include Arista Networks, Baidu, Chevron, Lexmark International, Occidental Petroleum and Salesforce.com.

Chris Lange | Jun 13, 2015 at 9:05 AM EDT

5 Top Performers for the Past Week

24/7 Wall St. has put together a list of companies that have outperformed the market this past week.

Chris Lange | Jun 8, 2015 at 1:00 PM EDT

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical…

Lee Jackson | May 22, 2015 at 9:15 AM EDT

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug…

1 … 29 30 31 32 33 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Top Health Care Earnings for the Week Ahead

Top Analyst Upgrades and Downgrades: Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone, Wells Fargo and More

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

5 Big Upcoming FDA Decisions Expected in July

4 Merrill Lynch Catalyst-Driven Stock Ideas to Buy Now

Is Big Pharma Advertising Getting Out of Control?

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

Top Analyst Upgrades and Downgrades: Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix, AT&T and More

4 Top New Growth Stock Picks From Jefferies

Key Analyst Sees Solid Upside in Eli Lilly

Top Analyst Upgrades and Downgrades: Bankrate, Eli Lilly, Embraer, Oracle, Southwest Air and More

Top Analyst Upgrades and Downgrades: Arista, Baidu, Chevron, Lexmark, Occidental, Salesforce and More

5 Top Performers for the Past Week

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

“Did you buy It from the mob?”: Dave Ramsey hosts floored by 21-year-old’s 30% truck loan

Kevin Warsh Would Be a Hawk at the Fed, but Productivity Boom Could Prevail

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

“Did you buy It from the mob?”: Dave Ramsey hosts floored by 21-year-old’s 30% truck loan

Eli Lilly : LLY

All Eli Lilly Articles

Top Health Care Earnings for the Week Ahead

Top Analyst Upgrades and Downgrades: Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone, Wells Fargo and More

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

5 Big Upcoming FDA Decisions Expected in July

4 Merrill Lynch Catalyst-Driven Stock Ideas to Buy Now

Is Big Pharma Advertising Getting Out of Control?

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

Top Analyst Upgrades and Downgrades: Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix, AT&T and More

4 Top New Growth Stock Picks From Jefferies

Key Analyst Sees Solid Upside in Eli Lilly

Top Analyst Upgrades and Downgrades: Bankrate, Eli Lilly, Embraer, Oracle, Southwest Air and More

Top Analyst Upgrades and Downgrades: Arista, Baidu, Chevron, Lexmark, Occidental, Salesforce and More

5 Top Performers for the Past Week

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

“Did you buy It from the mob?”: Dave Ramsey hosts floored by 21-year-old’s 30% truck loan

Kevin Warsh Would Be a Hawk at the Fed, but Productivity Boom Could Prevail

Featured Reads

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Half of America Still Feels Financially Exposed Despite 8% Jump in Security